EPM
CELG

Equitec Proprietary Markets’s Celgene Corp CELG Stock Holding History

Equitec Proprietary Markets’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-7,210
Closed -$807K – 694
2014
Q4 		$807K Buy
+7,210
New +$760K 0.04% 113

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Equitec Proprietary Markets's CELG Position: Q1 2015 in Review

Equitec Proprietary Markets sold out of Celgene Corp (CELG) in Q1 2015, closing a stake of 7,210 shares — an estimated $807K sold.

Equitec Proprietary Markets first reported a position in CELG in Q4 2014 and held it in 1 quarter. The position peaked at $807K in Q4 2014. 1,193 funds tracked by Wall St. Rank hold CELG as of Q1 2015.

  • Equitec Proprietary Markets reported no remaining Celgene Corp position as of Q1 2015 after selling out during the quarter.
  • Equitec Proprietary Markets sold 7,210 Celgene Corp shares in Q1 2015, an estimated $807K.
  • Equitec Proprietary Markets first reported a position in Celgene Corp in Q4 2014 and held it in 1 quarter.
  • Equitec Proprietary Markets's Celgene Corp position peaked at $807K in Q4 2014.
  • 1,193 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2015.

Based on Equitec Proprietary Markets's 13F filing for Q1 2015, filed 7 May 2015.